By Louis Mosley

There is a recurring pattern in British public life. A government programme begins to show measurable results. Its political opponents, who raised objections before any development work commenced, seek out a critical study. A think-tank produces one. A newspaper amplifies it. And a nation that routinely struggles to deliver major infrastructure — whether railways, reservoirs, or functional hospital discharge processes — congratulates itself on its scepticism.

This week, that cycle has turned its attention to Optica. Optica is a hospital discharge tool developed by an NHS organisation, North of England Care System Support, operating on the NHS Federated Data Platform, which is supplied by Palantir under a contract awarded in late 2023, valued at up to £330 million over seven years — one of the largest software engagements in the NHS's history. The Health Foundation, a well-regarded think tank, published an analysis concluding there was "no noticeable improvement" in discharge delays associated with Optica's use.

The stakes are considerable. Delayed discharges — often referred to as delayed transfers of care — have been a chronic and costly problem for the NHS for over a decade, occupying thousands of hospital beds each day that would otherwise be available for incoming patients, compounding winter pressures and emergency department crowding.

However, the Health Foundation reached its conclusion because it apparently did not fully account for what the tool was designed to address, and consequently which patient cohort should form the basis of the study.

Hospitals handle two distinct categories of discharge. The majority are straightforward: a ward sends a patient home with no ongoing care arrangements needed. Clinical guidance requires these cases to move quickly, and they generally do. Complex discharges, by contrast, involve patients who have typically spent weeks in hospital. These cases require someone to secure a care home placement, order specialised equipment, arrange transport, and brief a district nurse. Such discharges demand coordination across the NHS, local authorities, independent care providers, and charitable organisations. These patients are smaller in number but experience the longest waits.

Results Speak for Themselves

Consider Jonathan, a patient representative of the population Optica was designed to serve. "When I suffered life-threatening complications following a rare abdominal cancer, I wanted to get straight to hospital," he recounted. "But once I started feeling better I just wanted to recover at home. The hospital and social care teams could all see and update my data so they could work together to see if they could discharge me more quickly." His experience is documented on the NHS Digital website.

When all hospital discharges are averaged together, patients like Jonathan effectively disappear from the data. But for long-stay patients specifically, NHS England's analysis demonstrates a 14.1–14.9 per cent reduction in delay-days when Optica is used. Even when NHS England applied the Health Foundation's own alternative methodology — but correctly restricted it to the same long-stay population — it still produced a positive result.

Two independent analytical approaches converge on the same finding: a genuine, measurable impact, even though the two methods differ on its precise magnitude. This methodological dispute underscores a broader challenge in digital health evaluation: attributing outcomes to a single intervention within a system as complex as the NHS, where staffing levels, seasonal demand, social care funding, and dozens of other variables shift constantly, is notoriously difficult.

The broader platform warrants similar evaluation. NHS Trusts using its surgical theatre tool have recorded 110,000 additional operations since adoption. Trusts employing its cancer pathway tool have achieved a 6.8 per cent improvement against the 28-day diagnosis standard. The programme holds a green delivery rating — one of only 30 among more than 200 major government projects — and is projected to deliver £5 in value for every £1 spent.

Can it be definitively proven that no other factor influenced these figures? No. And the programme states this explicitly in writing: following a review by the statistics regulator, every published figure now carries a causal caveat. Notably, comparable health technologies such as virtual wards and electronic patient record systems carry no such disclaimers. Furthermore, where rigorous independent testing has occurred, the results have been positive: an evaluation by Imperial College found that the theatre tool demonstrably improved surgical theatre utilisation.

Software cannot materialise a care home bed where none exists. When social care capacity is the fundamental bottleneck, no technology can resolve that deficit. What this platform does is render the problem visible — identifying who is waiting, why they are waiting, and where the obstruction lies — so discharge teams cease losing days to manual spreadsheet tracking and telephone follow-ups.

This is fundamentally about patients: elderly and vulnerable individuals returning home sooner and in better health. The commitment remains to supporting the clinicians and care coordinators who facilitate that process every single day.